Change.org petition to fund and expedite BC-007 research
BC007 NOW- Chance of a cure for millions of suffering people
From the English description
call on the German government to financially support the approval studies of the company Berlin Cures GmbH for the drug BC 007 and to remove...
frontiers in Systems Neuroscience
Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Result in Sustained Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by Pereira, Bateman et al
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex...
The US Food and Drug Administration (FDA) has approved efgartigimod (Vyvgart, argenx), a first-in-class, targeted therapy for adults with generalized myasthenia gravis (gMG) who test positive for the antiacetylcholine receptor (AChR) antibody...
Full text at...
Evelien and I were interested in what clinical trials are currently planned or ongoing for ME/CFS. It can take many years to conduct a clinical trial and report the results, so we wanted to know what we can expect to come out in the next years.
A search of databases that register clinical...
Alzheimer's drug development tends to focus on protein aggregates in the brain. And they've all failed.
Alzheimer’s disease: why insulin is a new suspect
https://theconversation.com/alzheimers-disease-why-insulin-is-a-new-suspect-97222
Wired: Bad results from drug trials no longer have a place to hide
In 2007, US Food and Drugs Administration (FDA) Amendments Act was passed. The law laid out many different ways to try and improve the way new drugs are developed, including a publicly-available database of all clinical trials...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.